RMGP Biopharma Investment Fund
Venture capitalHerzliya · Seed–Series A · 6 people tracked
Investment thesis
RMGP Biopharma Investment Fund invests in early-stage therapeutic companies, partnering with OrbiMed, Johnson & Johnson, and Takeda through the FutuRx incubator. The fund is managed by RM Global Healthcare Fund Management.
Team · 6 people
from public directoriesInvestments · 1 tracked
founders shown can be your intro pathWest Hills, US
Board seatAssaf Keret· per SEC Form D · $5.5M raise · filed Aug 2020
Co-investorsDecheng CapitalNovartis Venture FundvenBio Global Strategic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does RMGP Biopharma Investment Fund invest at?
- RMGP Biopharma Investment Fund invests at the Seed, Series A stages.
- What sectors does RMGP Biopharma Investment Fund focus on?
- RMGP Biopharma Investment Fund focuses on Biotech.
- Where is RMGP Biopharma Investment Fund located?
- RMGP Biopharma Investment Fund is headquartered in Herzliya, IL.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.